Circulating Levels of Pro-inflammatory Cytokines in Patients with Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

被引:2
作者
Hadinia, Abolghasem [1 ]
Doustimotlagh, Amir Hossein [2 ,3 ]
Goodarzi, Hamed Reza [1 ]
Arya, Arash [4 ]
Jafarinia, Mojtaba [1 ]
机构
[1] Islamic Azad Univ, Marvdasht Branch, Dept Genet, Marvdasht, Iran
[2] Yasuj Univ Med Sci, Fac Med, Cellular & Mol Res Ctr, Yasuj, Iran
[3] Yasuj Univ Med Sci, Fac Med, Dept Clin Biochem, Yasuj, Iran
[4] Yasuj Univ Med Sci, Internal Med, Yasuj, Iran
关键词
Interleukin-1; beta; Interleukin-6; Non-Alcoholic Fatty Liver; Non-Alcoholic Steatohepatitis; Tumor Necrosis Factor-alpha; TUMOR-NECROSIS-FACTOR; INSULIN-RESISTANCE; FACTOR-ALPHA; OXIDATIVE STRESS; FOLLOW-UP; ADIPOKINES; NASH; PROGRESSION;
D O I
10.22034/iji.2019.80284
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Pro-inflammatory cytokines are associated with systemic inflammatory responses. Objective: To investigate the levels of pro-inflammatory cytokines (IL-1 beta, IL-6, and TNF-alpha) in patients with non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH) compared to healthy individuals. Methods: This case-control study was conducted on 30 patients with NAFL, 30 patients with NASH, and 30 healthy volunteers. The plasma level of IL-1 beta, IL-6, and TNF-alpha were determined by ELISA, and biochemical parameters were measured using colorimetric methods. Results: IL-1 beta and IL-6 levels were significantly higher in patients with NASH compared with NAFL and control group. However, TNF-alpha levels had no significant variations in NAFL and NASH patients compared to the control group (p=0.903 and p=0.960, respectively). Conclusion: Results showed that the levels of ALT activity and pro-inflammatory cytokines were higher in patients with NASH compared to control and NAFL subjects; Therefore, steatosis and inflammation develop as a result of excessive pro-inflammatory factors in NASH.
引用
收藏
页码:327 / 333
页数:7
相关论文
共 50 条
  • [41] Association of Obestatin, Ghrelin, and Inflammatory Cytokines in Obese Patients with Non-alcoholic Fatty Liver Disease
    Estep, Michael
    Abawi, Massih
    Jarrar, Mohammed
    Wang, Lei
    Stepanova, Maria
    Elariny, Hazem
    Moazez, Amir
    Goodman, Zachary
    Chandhoke, Vikas
    Baranova, Ancha
    Younossi, Zobair M.
    OBESITY SURGERY, 2011, 21 (11) : 1750 - 1757
  • [42] Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course
    Cortez-Pinto, H
    Camilo, ME
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2004, 18 (06) : 1089 - 1104
  • [43] THE ROLE OF BLOOD GROUPS IN NON-ALCOHOLIC FATTY LIVER DISEASE AND NON-ALCOHOLIC STEATOHEPATITIS
    Karagoz, Hatice
    Erden, Abdulsamet
    Ozer, Ozerhan
    Cetinkaya, Ali
    Avci, Deniz
    Gencer, Vedat
    Arik, Ferhat
    Kalan, Ugur
    Gorkem, Hasan
    Karaman, Hatice
    Karaman, Ahmet
    ACTA MEDICA MEDITERRANEA, 2017, 33 (02): : 205 - 210
  • [44] Association of Obestatin, Ghrelin, and Inflammatory Cytokines in Obese Patients with Non-alcoholic Fatty Liver Disease
    Michael Estep
    Massih Abawi
    Mohammed Jarrar
    Lei Wang
    Maria Stepanova
    Hazem Elariny
    Amir Moazez
    Zachary Goodman
    Vikas Chandhoke
    Ancha Baranova
    Zobair M. Younossi
    Obesity Surgery, 2011, 21 : 1750 - 1757
  • [45] Nonalcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis in Childhood: Endocrine-Metabolic "Mal-Programming"
    Manti, Sara
    Romano, Claudio
    Chirico, Valeria
    Filippelli, Martina
    Cuppari, Caterina
    Loddo, Italia
    Salpietro, Carmelo
    Arrigo, Teresa
    HEPATITIS MONTHLY, 2014, 14 (05)
  • [46] Non-alcoholic fatty liver disease in inflammatory bowel disease patients
    Karaivazoglou, Katerina
    Konstantakis, Christos
    Tourkochristou, Evanthia
    Assimakopoulos, Stelios F.
    Triantos, Christos
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 32 (08) : 903 - 906
  • [47] Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: Current Issues and Future Perspectives in Preclinical and Clinical Research
    Berardo, Clarissa
    Di Pasqua, Laura Giuseppina
    Cagna, Marta
    Richelmi, Plinio
    Vairetti, Mariapia
    Ferrigno, Andrea
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (24) : 1 - 30
  • [48] Circulating resistin is elevated in patients with non-alcoholic fatty liver disease and is associated with steatosis, portal inflammation, insulin resistance and nonalcoholic steatohepatitis scores
    Senates, E.
    Colak, Y.
    Yesil, A.
    Coskunpinar, E.
    Sahin, O.
    Kahraman, O. T.
    Senates, B. Erkalma
    Tuncer, I.
    MINERVA MEDICA, 2012, 103 (05) : 369 - 376
  • [49] Double Trouble: How Microbiome Dysbiosis and Mitochondrial Dysfunction Drive Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
    Bahitham, Wesam
    Alghamdi, Siraj
    Omer, Ibrahim
    Alsudais, Ali
    Hakeem, Ilana
    Alghamdi, Arwa
    Abualnaja, Reema
    Sanai, Faisal M.
    Rosado, Alexandre S.
    Sergi, Consolato M.
    BIOMEDICINES, 2024, 12 (03)
  • [50] NASH (Non-Alcoholic Steatohepatitis): Fatty Liver or Fatal Liver Disease?
    Roeb, E.
    ZENTRALBLATT FUR CHIRURGIE, 2014, 139 (02): : 168 - 174